$2.60
4.00%
Nasdaq, Jul 03, 10:53 pm CET
ISIN
US59503A1051
Symbol
MBOT
Sector
Industry

Microbot Medical Inc Stock price

$2.60
-0.13 4.76% 1M
+0.46 21.50% 6M
+1.48 132.14% YTD
+1.55 147.62% 1Y
-2.41 48.10% 3Y
-4.45 63.12% 5Y
-862.48 99.70% 10Y
-70,953.40 100.00% 20Y
Nasdaq, Closing price Thu, Jul 03 2025
+0.10 4.00%
ISIN
US59503A1051
Symbol
MBOT
Sector
Industry

Key metrics

Basic
Market capitalization
$94.6m
Enterprise Value
$64.2m
Net debt
positive
Cash
$30.4m
Shares outstanding
34.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | 30.9
EV/Sales
- | 21.0
EV/FCF
negative
P/B
3.1
Financial Health
Equity Ratio
58.5%
Return on Equity
-324.2%
ROCE
-42.3%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $3.1m
EBITDA
$-12.2m | -
EBIT
$-12.3m | $-13.4m
Net Income
$-11.7m | $-11.3m
Free Cash Flow
$-9.3m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-18.0% | -
EBIT
-17.6%
Net Income
-13.6% | 0.9%
Free Cash Flow
-19.4%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -370.6%
Free Cash Flow
-
More
EPS
$-0.4
FCF per Share
$-0.3
Short interest
22.4%
Employees
20
Rev per Employee
$0.0
Show more

Is Microbot Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,967 stocks worldwide.

Microbot Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Microbot Medical Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Microbot Medical Inc forecast:

Buy
86%
Hold
14%

Financial data from Microbot Medical Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 5.34 5.34
32% 32%
-
- Research and Development Expense 6.92 6.92
31% 31%
-
-12 -12
18% 18%
-
- Depreciation and Amortization 0.08 0.08
20% 20%
-
EBIT (Operating Income) EBIT -12 -12
18% 18%
-
Net Profit -12 -12
14% 14%
-

In millions USD.

Don't miss a Thing! We will send you all news about Microbot Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Microbot Medical Inc Stock News

Neutral
GlobeNewsWire
7 days ago
Automatic inclusion in the appropriate growth and value style indexes Automatic inclusion in the appropriate growth and value style indexes
Neutral
GlobeNewsWire
20 days ago
HINGHAM, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY Endovascular Robotic System, announced that it has been granted a critical patent in China by the China National Intellectual Property Administration (CNIPA), a key step in the Company's global IP expansion strategy.
Neutral
GlobeNewsWire
28 days ago
HINGHAM, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY Endovascular Robotic System, today announced the continued expansion of its commercial team in preparation for the anticipated U.S. launch of the LIBERTY System, which is projected during the third quarter of 2025.
More Microbot Medical Inc News

Company Profile

Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

Head office United States
CEO Harel Gadot
Employees 20
Founded 1988
Website www.microbotmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today